CECCARELLI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.136
EU - Europa 950
AS - Asia 133
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 2.223
Nazione #
US - Stati Uniti d'America 1.132
GB - Regno Unito 260
IE - Irlanda 216
IT - Italia 163
CN - Cina 80
SE - Svezia 80
UA - Ucraina 63
FR - Francia 43
DE - Germania 39
FI - Finlandia 33
VN - Vietnam 21
ES - Italia 15
SG - Singapore 14
TR - Turchia 11
CZ - Repubblica Ceca 9
RU - Federazione Russa 9
BE - Belgio 7
GR - Grecia 5
NL - Olanda 5
CA - Canada 4
SA - Arabia Saudita 3
IN - India 2
UG - Uganda 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
EE - Estonia 1
IL - Israele 1
IR - Iran 1
PT - Portogallo 1
Totale 2.223
Città #
Southend 237
Dublin 215
Fairfield 195
Chandler 124
Ashburn 123
Woodbridge 73
Seattle 71
Siena 68
Houston 66
Wilmington 63
Cambridge 62
Ann Arbor 56
Jacksonville 49
New York 36
Princeton 30
Helsinki 26
Beijing 22
Dearborn 22
Dong Ket 21
Nanjing 14
Florence 11
Málaga 11
San Diego 11
Boardman 8
Izmir 8
Milan 8
Moscow 8
Munich 8
Washington 8
Brussels 7
San Mateo 7
Brno 6
London 6
Shanghai 6
Singapore 6
Shenyang 5
Agliana 4
Hefei 4
Jiaxing 4
Nanchang 4
Rome 4
Düsseldorf 3
Kunming 3
Perugia 3
Riyadh 3
Amsterdam 2
Auburn Hills 2
Casoria 2
Changsha 2
Duncan 2
Fremont 2
Genoa 2
Jinan 2
Kalamata 2
Kifissia 2
Los Angeles 2
Oulu 2
Phoenix 2
Pontedera 2
Prague 2
Redwood City 2
Tianjin 2
Toronto 2
Turin 2
Zhengzhou 2
Atlanta 1
Barcelona 1
Bari 1
Bologna 1
Borås 1
Buffalo 1
Cagliari 1
Caserta 1
Catania 1
Cleveland 1
Cosenza 1
Esslingen am Neckar 1
Falkenstein 1
Groningen 1
Guangzhou 1
Hangzhou 1
Hebei 1
Hendon 1
Hounslow 1
Kilburn 1
Livorno 1
Madrid 1
Menlo Park 1
Monmouth Junction 1
Montespertoli 1
Montevarchi 1
Napoli 1
Ningbo 1
Norwalk 1
Nova Milanese 1
Olomouc 1
Oviedo 1
Paris 1
Ponte Buggianese 1
Prato 1
Totale 1.804
Nome #
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 211
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 184
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 183
Peripheral biomarkers' panel for severe COVID-19 patients 179
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 175
Choreoathetosis associated with non-chetotic hyperglycemia 173
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 165
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 160
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 159
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 134
The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women 116
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 102
Hyperglycemia and diabetes induced by glucocorticoids in nondiabetic and diabetic patients: Revision of literature and personal considerations 96
Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes – The TOSCA.IT study 80
Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes 78
Clinical impact of oral antidiabetic medications in heart failure patients 56
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 33
Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification 27
Totale 2.311
Categoria #
all - tutte 7.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020435 41 14 23 62 29 63 50 53 37 30 17 16
2020/2021395 13 29 6 58 45 26 13 41 52 49 29 34
2021/2022304 20 46 10 23 16 10 18 13 26 27 38 57
2022/2023361 27 57 46 43 35 70 4 19 25 16 8 11
2023/2024449 18 15 39 40 17 124 132 4 8 11 4 37
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 2.311